Therefore, boosting transmission-blocking immune responses, including mucosal IgA, remains one of the key challenges at this point in time and can potentially end the seasonal recurrence of COVID-19 outbreaks [28,29,46,47,48]. Here, CD79A is linked to COVID-19.